Overview
Venture capital fund financing MedTech start-ups.
Deals · 12mo
0
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Supira Medical | Mar 2025Participated | $120 MSeries E | |
Adona Medical | Jul 2024Participated | $34 MSeries C | |
Laza Medical | Dec 2023Participated | $36 MSeries A | |
Supira Medical | Nov 2023Participated | $40 MSeries D | |
Akura Medical | Oct 2023Participated | $35 MSeries B | |
Myra Vision | Jun 2023Participated | $25 MSeries B | |
Tioga Cardiovascular | Feb 2023Participated | $30 MSeries C | |
Atia Vision | Aug 2022Participated | $42 MSeries E | |
Adona Medical | May 2022Participated | $38 MSeries B | |
Supira Medical | Feb 2022Participated | $30 MSeries C | |
Akura Medical | Jan 2022Participated | $25 MSeries A | |
Supira Medical | Mar 2025Participated | $120 MSeries E | |
Adona Medical | Jul 2024Participated | $34 MSeries C | |
Laza Medical | Dec 2023Participated | $36 MSeries A | |
Supira Medical | Nov 2023Participated | $40 MSeries D | |
Akura Medical | Oct 2023Participated | $35 MSeries B | |
Myra Vision | Jun 2023Participated | $25 MSeries B | |
Tioga Cardiovascular | Feb 2023Participated | $30 MSeries C | |
Atia Vision | Aug 2022Participated | $42 MSeries E | |
Adona Medical | May 2022Participated | $38 MSeries B | |
Supira Medical | Feb 2022Participated | $30 MSeries C | |
Akura Medical | Jan 2022Participated | $25 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 2 |
| Series B | 0 | 3 |
| Series C+ | 0 | 6 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jan '22 | 1 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 1 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 10 |
| $50M-$100M | 0 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 10 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Cormorant Asset Management | 10 |
| The Capital Partnership | 10 |
| AMED Ventures | 8 |
| Unorthodox Ventures | 5 |
| 415 Capital | 3 |
| Shifamed | 3 |
| Excelestar Ventures | 2 |
| Dara Holdings | 1 |
| GE Healthcare | 1 |
| Lilly Asia Ventures | 1 |
| Novo Holdings | 1 |
| Qatar Investment Authority | 1 |
| TCP Health Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 11 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range